LAG3 and pancreatic ductal adenocarcinoma: Moreover, predicting the role of LAG3 in breast cancer and pancreatic ductal adenocarcinoma prognosis is controversial, and we believe that the discrepancy between these two tumors can be attributed to tumor heterogeneity.